Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
暂无分享,去创建一个
G. Coukos | R. Buckanovich | R. Reynolds | K. McLean | J. Conejo-Garcia | Heather L Pulaski | I. Silva | Greg Spahlinger | A. Kueck | Ines A. Silva